Portage Biotech Files 6-K Report
Ticker: ATON · Form: 6-K · Filed: Jun 27, 2025 · CIK: 1095435
Sentiment: neutral
Topics: sec-filing, 6-K, registration-statement
TL;DR
Portage Biotech filed a 6-K, nothing major but it's linked to their S-8 and F-3 filings.
AI Summary
Portage Biotech Inc. filed a Form 6-K on June 27, 2025, for the month of June 2025. The filing is a Report of Foreign Private Issuer and is incorporated by reference into their Form S-8 (File No. 333-275842) and Form F-3 (File No. 333-286961) registration statements.
Why It Matters
This filing provides routine updates for investors and is incorporated into existing registration statements, indicating ongoing compliance and potential future stock issuances.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) and does not appear to contain significant new financial or operational information.
Key Players & Entities
- PORTAGE BIOTECH INC. (company) — Filer
- 001-40086 (company) — SEC File Number
- 333-275842 (company) — Form S-8 File Number
- 333-286961 (company) — Form F-3 File Number
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the filing date for this report?
The filing date is June 27, 2025.
Which registration statements does this 6-K filing get incorporated into?
This filing is incorporated by reference into Portage Biotech Inc.'s registration statement on Form S-8 (File No. 333-275842) and Form F-3, as amended (File No. 333-286961).
What is the principal executive office address of Portage Biotech Inc.?
The principal executive office is located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
Does Portage Biotech Inc. file annual reports under Form 20-F or Form 40-F?
Yes, Portage Biotech Inc. files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 27, 2025 regarding PORTAGE BIOTECH INC. (ATON).